Enterolactone has stronger effects than enterodiol on ovarian cancer

Enterolactone has stronger effects than enterodiol on ovarian cancer

Abstract Background Ovarian cancer is one of the three leading gynecological malignancies, characterized by insidious growth, highly frequent metastasis, and quick development of drug resistance. As a result, this disease has low 5-year survival rates. Estrogen receptor inhibitors were commonly used...

Full description

Bibliographic Details
Main Authors: Huidi Liu, Jianrui Liu, Siwen Wang, Zheng Zeng, Ting Li, Yongfang Liu, Emilio Mastriani, Qing-Hai Li, Hong-Xia Bao, Yu-Jie Zhou, Xiaoyu Wang, Sijing Hu, Shan Gao, Yingying Qi, Zhihang Shen, Hongyue Wang, Miao Yu, Tingting Gao, Randal N. Johnston, Shu-Lin Liu
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Journal of Ovarian Research
Subjects:
Ovarian cancer
Enterodiol
Enterolactone
Anti-cancer
Online Access:http://link.springer.com/article/10.1186/s13048-017-0346-z

Internet

http://link.springer.com/article/10.1186/s13048-017-0346-z

Similar Items